| 3.56 Delayed Data As of 3:59pm ET |  +0.03 / +0.85%Today’s Change | 3.20 Today|||52-Week Range 10.04 | -3.00% Year-to-Date |
| Previous close | 3.53 |
| Today’s open | 3.53 |
| Day’s range | 3.51 - 3.64 |
| Volume | 111,928 |
| Average volume (3 months) | 180,542 |
| Market cap | $109.9M |
| Earnings growth (last year) | +37.27% |
| Earnings growth (this year) | +6.58% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.99 |
| Today’s change | Today’s % change | |
|---|---|---|
| NBSENeuBase Therapeutics... | +0.35 | +5.61% |
| ATXIAvenue Therapeutics ... | +0.13 | +2.15% |
| SVRASavara Inc | +0.12 | +4.94% |
| ALNAAllena Pharmaceutica... | +0.07 | +1.66% |
| Next reporting date | November 4, 2019 |
| EPS forecast (this quarter) | -$0.42 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$46.9M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer Richard A. Miller |
CFO & Principal Accounting Officer Leiv Lea |
Corporate headquarters Burlingame, California |
